SRS/SBRT for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on the use and effectiveness of SRS/SBRT, precise radiation therapies for treating life-threatening tumors and other conditions. Researchers collect data to evaluate the long-term effectiveness of these treatments and to determine optimal usage. It suits individuals diagnosed with benign (non-cancerous) or malignant (cancerous) tumors or conditions deemed treatable with these therapies by a doctor. Participants must agree to join and provide their consent. As a Phase 3 trial, this treatment represents the final step before FDA approval, offering participants an opportunity to contribute to groundbreaking research.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that SRS/SBRT is safe for treating life-threatening tumors and other diseases?
Research has shown that SRS (Stereotactic Radiosurgery) and SBRT (Stereotactic Body Radiation Therapy) are generally safe and well-tolerated. These methods have been used for many years and are known for their safety and effectiveness.
One study found that serious side effects occurred in about 9.4% of patients over three years. The most common serious side effect was pneumonitis, an inflammation of the lungs, which occurred in a small number of cases.
Overall, these treatments are considered safe for most patients, especially when used for specific conditions like tumors. The long history of using SRS and SBRT supports their safety record.12345Why are researchers excited about this trial?
Researchers are excited about SRS (Stereotactic Radiosurgery) and SBRT (Stereotactic Body Radiotherapy) because these treatments offer a precise and non-invasive alternative to traditional options like surgery or standard radiation therapy. Unlike conventional radiation, which can affect surrounding healthy tissues, SRS/SBRT delivers high doses of radiation with pinpoint accuracy, minimizing damage to nearby areas. This means fewer side effects and potentially quicker recovery times for patients. Plus, these treatments can be completed in fewer sessions, making the process more convenient and less burdensome for patients.
What evidence suggests that SRS/SBRT is effective for treating life-threatening tumors and other diseases?
Research has shown that SRS (Stereotactic Radiosurgery) and SBRT (Stereotactic Body Radiation Therapy), studied in this trial, can effectively treat various tumor types. These methods often match or surpass traditional radiation treatments. For instance, SBRT has successfully treated some prostate cancers, achieving survival rates similar to standard treatments. Patients with early-stage lung cancer treated with SBRT have also demonstrated promising long-term results. Overall, these treatments are effective and cost-efficient, offering a strong option for patients with serious tumors.678910
Who Is on the Research Team?
Anand Mahadevan, MD
Principal Investigator
The Radiosurgery Society
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Patients receive SRS/SBRT treatment for their condition
Follow-up
Participants are monitored for survival, recurrence, and treatment toxicity
What Are the Treatments Tested in This Trial?
Interventions
- SRS/SBRT
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Radiosurgery Society
Lead Sponsor
VisionTree
Collaborator